Urinary Extracellular Vesicles and Their miRNA Cargo in Patients with Fabry Nephropathy

Current biomarkers of Fabry nephropathy lack sensitivity in detecting early kidney damage and do not predict progression of nephropathy. Urinary extracellular vesicles (uEVs) and their molecular cargo could reflect early changes in renal impairment as they are secreted by the cells lining the urinar...

Full description

Bibliographic Details
Main Authors: Tina Levstek, Teo Mlinšek, Marija Holcar, Katja Goričar, Metka Lenassi, Vita Dolžan, Bojan Vujkovac, Katarina Trebušak Podkrajšek
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Genes
Subjects:
Online Access:https://www.mdpi.com/2073-4425/12/7/1057
_version_ 1797527084179914752
author Tina Levstek
Teo Mlinšek
Marija Holcar
Katja Goričar
Metka Lenassi
Vita Dolžan
Bojan Vujkovac
Katarina Trebušak Podkrajšek
author_facet Tina Levstek
Teo Mlinšek
Marija Holcar
Katja Goričar
Metka Lenassi
Vita Dolžan
Bojan Vujkovac
Katarina Trebušak Podkrajšek
author_sort Tina Levstek
collection DOAJ
description Current biomarkers of Fabry nephropathy lack sensitivity in detecting early kidney damage and do not predict progression of nephropathy. Urinary extracellular vesicles (uEVs) and their molecular cargo could reflect early changes in renal impairment as they are secreted by the cells lining the urinary tract. We aimed to conduct a proof-of-concept study to investigate whether analysis of uEV characteristics and expression of uEV-derived microRNAs (miRNAs) could be applicable in studies to predict the development and progression of nephropathy in Fabry disease. A total of 20 Fabry patients were divided into two groups, depending on the presence of nephropathy. Chronological urine samples collected during 10-year follow-up were used for uEVs isolation with size exclusion chromatography. Nanoparticle tracking analysis was used to determine concentration and size of uEVs. We evaluated the expression of five uEV-derived miRNAs by qPCR (miR-23a-3p, miR-29a-3p, miR-30b-5p, miR-34a-5p, miR-200a-3p). There was no difference in the concentration and size of uEVs between patients with and without nephropathy at last follow-up or longitudinally. However, we found increased expression of miR-29a-3p and miR-200a-3p in uEVs isolated from chronological samples of patients with Fabry nephropathy. This may indicate an attempt by the organism to prevent the progression of renal damage leading to end-stage renal disease as previously reported in type 1 diabetes. In addition, we found an increased expression of miR-30b-5p in the 10-year period in uEVs of patients without renal dysfunction. miR-30b-5 was reported to have a protective role in podocyte injury and may possibly be important in Fabry nephropathy. These findings indicate that uEVs and their molecular cargo could be a promising target of studies focusing on elucidation of Fabry nephropathy. Nevertheless, total concentration and size of uEVs were neither indicative of the presence nor progression of Fabry nephropathy, while the role of the analyzed miRNAs in Fabry nephropathy progression was merely indicated and needs further in-depth studies.
first_indexed 2024-03-10T09:37:59Z
format Article
id doaj.art-27d38e35edee474796d47cf45deaf202
institution Directory Open Access Journal
issn 2073-4425
language English
last_indexed 2024-03-10T09:37:59Z
publishDate 2021-07-01
publisher MDPI AG
record_format Article
series Genes
spelling doaj.art-27d38e35edee474796d47cf45deaf2022023-11-22T03:50:57ZengMDPI AGGenes2073-44252021-07-01127105710.3390/genes12071057Urinary Extracellular Vesicles and Their miRNA Cargo in Patients with Fabry NephropathyTina Levstek0Teo Mlinšek1Marija Holcar2Katja Goričar3Metka Lenassi4Vita Dolžan5Bojan Vujkovac6Katarina Trebušak Podkrajšek7Institute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1000 Ljubljana, SloveniaInstitute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1000 Ljubljana, SloveniaInstitute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1000 Ljubljana, SloveniaInstitute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1000 Ljubljana, SloveniaInstitute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1000 Ljubljana, SloveniaInstitute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1000 Ljubljana, SloveniaCentre for Fabry Disease, General Hospital Slovenj Gradec, Gosposvetska cesta 1, 2380 Slovenj Gradec, SloveniaInstitute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1000 Ljubljana, SloveniaCurrent biomarkers of Fabry nephropathy lack sensitivity in detecting early kidney damage and do not predict progression of nephropathy. Urinary extracellular vesicles (uEVs) and their molecular cargo could reflect early changes in renal impairment as they are secreted by the cells lining the urinary tract. We aimed to conduct a proof-of-concept study to investigate whether analysis of uEV characteristics and expression of uEV-derived microRNAs (miRNAs) could be applicable in studies to predict the development and progression of nephropathy in Fabry disease. A total of 20 Fabry patients were divided into two groups, depending on the presence of nephropathy. Chronological urine samples collected during 10-year follow-up were used for uEVs isolation with size exclusion chromatography. Nanoparticle tracking analysis was used to determine concentration and size of uEVs. We evaluated the expression of five uEV-derived miRNAs by qPCR (miR-23a-3p, miR-29a-3p, miR-30b-5p, miR-34a-5p, miR-200a-3p). There was no difference in the concentration and size of uEVs between patients with and without nephropathy at last follow-up or longitudinally. However, we found increased expression of miR-29a-3p and miR-200a-3p in uEVs isolated from chronological samples of patients with Fabry nephropathy. This may indicate an attempt by the organism to prevent the progression of renal damage leading to end-stage renal disease as previously reported in type 1 diabetes. In addition, we found an increased expression of miR-30b-5p in the 10-year period in uEVs of patients without renal dysfunction. miR-30b-5 was reported to have a protective role in podocyte injury and may possibly be important in Fabry nephropathy. These findings indicate that uEVs and their molecular cargo could be a promising target of studies focusing on elucidation of Fabry nephropathy. Nevertheless, total concentration and size of uEVs were neither indicative of the presence nor progression of Fabry nephropathy, while the role of the analyzed miRNAs in Fabry nephropathy progression was merely indicated and needs further in-depth studies.https://www.mdpi.com/2073-4425/12/7/1057Fabry nephropathyurinary extracellular vesiclesbiomarkermiRNA expressionNTAFabry disease
spellingShingle Tina Levstek
Teo Mlinšek
Marija Holcar
Katja Goričar
Metka Lenassi
Vita Dolžan
Bojan Vujkovac
Katarina Trebušak Podkrajšek
Urinary Extracellular Vesicles and Their miRNA Cargo in Patients with Fabry Nephropathy
Genes
Fabry nephropathy
urinary extracellular vesicles
biomarker
miRNA expression
NTA
Fabry disease
title Urinary Extracellular Vesicles and Their miRNA Cargo in Patients with Fabry Nephropathy
title_full Urinary Extracellular Vesicles and Their miRNA Cargo in Patients with Fabry Nephropathy
title_fullStr Urinary Extracellular Vesicles and Their miRNA Cargo in Patients with Fabry Nephropathy
title_full_unstemmed Urinary Extracellular Vesicles and Their miRNA Cargo in Patients with Fabry Nephropathy
title_short Urinary Extracellular Vesicles and Their miRNA Cargo in Patients with Fabry Nephropathy
title_sort urinary extracellular vesicles and their mirna cargo in patients with fabry nephropathy
topic Fabry nephropathy
urinary extracellular vesicles
biomarker
miRNA expression
NTA
Fabry disease
url https://www.mdpi.com/2073-4425/12/7/1057
work_keys_str_mv AT tinalevstek urinaryextracellularvesiclesandtheirmirnacargoinpatientswithfabrynephropathy
AT teomlinsek urinaryextracellularvesiclesandtheirmirnacargoinpatientswithfabrynephropathy
AT marijaholcar urinaryextracellularvesiclesandtheirmirnacargoinpatientswithfabrynephropathy
AT katjagoricar urinaryextracellularvesiclesandtheirmirnacargoinpatientswithfabrynephropathy
AT metkalenassi urinaryextracellularvesiclesandtheirmirnacargoinpatientswithfabrynephropathy
AT vitadolzan urinaryextracellularvesiclesandtheirmirnacargoinpatientswithfabrynephropathy
AT bojanvujkovac urinaryextracellularvesiclesandtheirmirnacargoinpatientswithfabrynephropathy
AT katarinatrebusakpodkrajsek urinaryextracellularvesiclesandtheirmirnacargoinpatientswithfabrynephropathy